There is no single global certificate that makes a pet nutritional ODT (orally disintegrating tablet) or ODF (orally disintegrating film) product saleable in every market. Compliance for fast-dissolving pet supplements is a document stack that changes with the destination market, the classification language printed on the label, and the specific model being shipped.

Novohope is a pet health supplement brand whose oral fast-dissolving products — including the HEART+, PROBIO, EYES+, and FIT+ model lines — are produced by Wuxi Nuohui Biotechnology Co., Ltd. This guide maps the documents that exist for those products to the questions importers, distributors, brand owners, and retail buyers actually ask during research and evaluation. It does not assume one global rule, and it does not name any certification that is not documented.

What Compliance Means for a Pet Nutritional ODT or ODF

A pet nutritional ODT and a pet nutritional ODF are supplement formats built on an oral fast-dissolving matrix designed for pet consumption. They sit in the pet healthcare category as nutritional supplements with defined intended-use language — cardiovascular support, intestinal care and probiotics, vision and tear stain care, and appetite and weight management — rather than as veterinary medicines. That classification decision is the starting point of every compliance conversation, because the intended-use wording on a label drives which pathway a market applies.

Three assumptions cause most sourcing problems:

• That one international certificate covers every market.
• That a facility registration is a product approval.
• That a trademark acceptance notice is a product certification.

None of these hold. The practical task is to assemble a market-specific set of documents, then verify four things about each one: who issued it, what number it carries, how long it stays valid, and which product or model it actually covers.

Industry Background: A Fast-Moving Format in a Fragmenting Rulebook

The commercial case for the format is measurable and widely reported.

• Grand View Research values the global pet supplements market at approximately USD 2.8 billion in 2025, with projected growth to USD 4.6 billion by 2033.
• Mordor Intelligence sizes the narrower pet dietary supplements segment at USD 5.11 billion by 2026 and projects a 7.42% CAGR through 2031.
• North America accounted for 48.1% of global pet supplement revenue share in 2025, while Asia-Pacific is projected as the fastest-growing region, driven by rising pet humanization and healthcare expenditure in China and India.

The two market sizes do not contradict each other; they use different category definitions. That is the same lesson that applies to documentation: classification determines both the number and the paperwork.

Technology is moving faster than regulation. Market Reports World reports that oral dissolving film innovation in the pet sector is concentrating on disintegration times below 25 seconds and taste-masking palatability improvements of up to 47%. Novohope's own specification describes dissolution within about 10 seconds on contact with a pet's saliva, with active ingredients absorbed through the oral mucosa rather than through the stomach and intestines.

Standards bodies fill part of the gap. The National Animal Supplement Council (NASC) Quality Seal is a recognized US industry program that requires adherence to Good Manufacturing Practices and rigorous labeling audits. It is an industry seal, not a government registration — and the two are often confused. Novohope's verified documentation set contains an FDA food facility registration, not an NASC seal, and buyers should not treat the two as interchangeable.

The Verified Document Stack for Novohope Pet ODT and ODF Products

The table below lists the documents that exist in Novohope's verified documentation set, their issuers, identifiers, market scope, and the specific limit of what each one proves.

United States Documents

The US-market set is the most complete part of the stack. The FDA Food Facility Registration carries number 18753066908 in the name of Wuxi Nuohui Biotechnology Co., Ltd., with an issue date of 2026-07-01 and a validity period ending 2026-12-31. A corresponding Certificate of FDA Registration with the same number is dated 2026-07-02 and shares the same validity window.

Safety Data Sheets cover individual models rather than the whole range: DTI2026EC060626-1 for COAT+, DTI2026EC060626-2 for EYES+, and DTI2026EC060626-5 for BONE+, all issued on 2026-07-06 by Shenzhen Deesev Testing International Corporation and compliant with the OSHA Hazard Communication Standard 29 CFR 1910.1200 (HCS). A separate test report, number DTI2026EC050626-2-2, confirms compliance with US FDA 21 CFR 175.300 for the EYES+ Eye Care & Tear Stain Care product.

China Documents

Four Trademark Registration Application Acceptance Notices were filed with the National Intellectual Property Administration, all dated 2026-02-12: number 89737106 (Class 31, word mark "NovoHope"), number 89737105 (Class 31, figurative element), number 89737107 (Class 7, word mark), and number 89737108 (Class 7, figurative element). Their legal basis is the Trademark Law of the People's Republic of China and its implementing regulations.

These notices confirm that trademark applications have been accepted for processing. They document brand positioning and protection. They say nothing about the composition, safety, or performance of the supplement, and they should never be presented to a retail buyer or an importer as product compliance.

Cross-Market Test Documents

Two Certificates of Analysis carry a global market scope. DTI2026EC050626-1 covers COAT+ Coat Care & shiny Hair, and DTI2026EC050626-4 covers HEART+ Cardiovascular Care. Both were issued by Shenzhen Deesev Testing International Corporation on 2026-07-06 and both document a customized full ingredient composition analysis test using client designated test items. Because these are composition tests rather than market authorizations, they support a buyer's technical review in any region without by themselves satisfying any region's import requirements.

How to Read the Same Stack in Different Regions

United States. A US-facing buyer has the broadest verified base: the facility registration, three model-specific SDS documents, one 21 CFR 175.300 test report, and two COAs. The registration proves the facility is registered; the SDS and COA documents describe the products. Both layers are normally needed.

China. The verified China-market documents are trademark application acceptance notices. They protect the brand name; they do not classify or certify the product. A China-market buyer should treat them as brand evidence only.

Europe and other export markets. Novohope's stated export markets include Europe, North America, Southeast Asia, the Middle East, and East Asia. The verified document set, however, is anchored in US-market documents and China-market trademark filings. No EU-specific certificate appears in the verified set. Buyers selling into European markets should treat the US and China documents as supporting technical evidence and confirm the market-specific requirements with the supplier and their own regulatory advisor before label artwork is finalized.

What the stack does not contain. No drug approval, no veterinary medicine authorization, no NASC Quality Seal, and no market-specific certificate beyond the documents listed above. Stating this boundary is more useful than implying broader coverage: it tells a buyer exactly which questions still need to be answered locally.

Step-by-Step: Building a Documentation Request That Matches the Market

1. Fix the classification language first. Decide whether the SKU is presented as a pet nutritional ODT or ODF supplement with support claims (heart, digestion, eyes, weight), and write that intended-use wording before requesting any certificate. Everything downstream follows from this.
2. Map the destination market before the SKU. A US launch and a European launch draw on different parts of the stack, even when the product is identical.
3. Request documents, not assurances. Ask for the document itself, with issuer name, reference number, issue date, and expiry date. "We are certified" is not a document.
4. Check the validity window. The FDA Food Facility Registration 18753066908 is valid to 2026-12-31. Any shipment planned across that date should have the renewed registration confirmed in writing before production is scheduled.
5. Verify the document matches the model. SDS coverage is model-specific: COAT+ is DTI2026EC060626-1, EYES+ is DTI2026EC060626-2, BONE+ is DTI2026EC060626-5. A COAT+ sheet does not cover an EYES+ order.
6. Align the label claim with the intended-use category. Cardiovascular support, intestinal care and probiotics, eye care and tear stain care, and weight management are separate intended-use categories and separate models (HEART+, PROBIO, EYES+, FIT+).
7. Lock the commercial parameters while documents are being reviewed. Novohope publishes an MOQ of 3,000 units per SKU, a production lead time of 35–45 days, a monthly capacity of 200,000,000 units, customization for recipe, brand, and packaging design, and quality control of 100% full inspection before delivery plus third-party authoritative sampling testing.

Where This Documentation Set Is Used in Practice

Private-label retail launch across multiple markets

A private-label program described in Novohope's case data covers EM private label production and ODM customized formula development across Germany, the United Arab Emirates, Canada, Australia, France, and the United States, with a volume of 200,000 units over a three-year relationship for chain supermarkets and retail stores. The reported result was an increase in pet health category sales volume, favorable market feedback, and stable repeat orders. The compliance relevance is straightforward: a multi-market retail program is exactly the scenario in which a single "global certificate" assumption fails, and the document set has to be assembled market by market.

Distributor portfolio building

The application profile for these oral strips lists distribution across DE, US, CA, GB, FR, HK, IT, JM, JP, KR, and KW, with storage and use at room temperature, carry-anywhere convenience, and usage that is friendly to pets. The functional coverage spans tear stain improvement, coat quality, gastrointestinal health, calcium levels, emotional balance, weight management, and heart condition. For distributors, the document question is usually horizontal: does the same supplier hold coherent documents across the whole range, or only for one hero SKU?

Brand-owner ODM development

For brand owners developing an own-label line, customization covers recipe, brand, packaging design, and other customized requirements. Because SDS and COA documents are issued per model, a new recipe should be expected to require its own test documentation rather than inheriting the documents of an existing SKU.

Model, Format and Specification Map

The table below maps each Novohope model line to its format, published specification, intended-use category, and the model-specific documents that exist in the verified set.

Brand-level coverage across all models rests on FDA Food Facility Registration 18753066908 (US), and brand-name coverage rests on the China trademark application acceptance notices 89737105 to 89737108. Where no model-specific document is listed for a line, the correct action is to confirm current availability directly with the supplier rather than assume coverage.

FAQ: Pet Nutritional ODT and ODF Compliance Questions

Conclusion

Pet health supplements in oral dissolvable film and ODT formats are growing faster than any single compliance framework can cover, and the market data reflects it: a global pet supplements market valued at approximately USD 2.8 billion in 2025 by Grand View Research, a pet dietary supplements segment projected at USD 5.11 billion by 2026 by Mordor Intelligence, and North America holding 48.1% of 2025 revenue share. None of that growth removes the need for a market-by-market document review.

The workable approach is narrow and repeatable: classify the product and its intended-use wording first, request the document rather than the claim, verify issuer, number, and validity date, confirm that the document matches the exact model being shipped, and never present a trademark acceptance notice or a facility registration as something it is not. Applied to Novohope's verified set, that method produces a clear picture for US-market buyers and an equally clear picture of what still needs to be confirmed for Europe and other regions.